HRMY Harmony Biosciences Holdings, Inc.
Harmony Biosciences is a U.S. commercial-stage pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs. Established in 2017 by founder Paragon Biosciences LLC, our mission is to positively impact the lives of those living with rare diseases who are so often underserved.
$37.09 +0.21 (0.57%)
As of 02/24/2021 15:59:56 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
USA
08/19/2020
56,889,111
61,924
$2,098,070,414
0.00%
SEC Edgar Online
10-Q
10-K
413197104
US4131971040
BKSGZN7
Common stocks
Mid cap
Health Care
Biotechnology
USA
USA
08/19/2020
56,889,111
61,924
$2,098,070,414
0.00%
SEC Edgar Online
10-Q
10-K
413197104
US4131971040
BKSGZN7
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-23.44
22.19
19.17
-77.40%
-66.86%
22.19
19.17
-77.40%
-66.86%